Holen Sie sich die Stockscreener-App
6.09
0.20%
-0.012
Handel nachbörslich:
6.07
-0.02
-0.33%
Schlusskurs vom Vortag:
$6.102
Offen:
$6.16
24-Stunden-Volumen:
13,905
Relative Volume:
0.18
Marktkapitalisierung:
$202.86M
Einnahmen:
$8.98M
Nettoeinkommen (Verlust:
$-31.39M
KGV:
-4.5448
EPS:
-1.34
Netto-Cashflow:
$-24.83M
1W Leistung:
+1.50%
1M Leistung:
+10.93%
6M Leistung:
-22.91%
1J Leistung:
-29.02%
1-Tages-Spanne:
$5.96
$6.16
1-Wochen-Bereich:
$5.84
$6.24
52-Wochen-Spanne:
$3.895
$11.42
Profound Medical Corp Stock (PROF) Company Profile
Firmenname
Profound Medical Corp
Sektor
Branche
Telefon
647-476-1350
Adresse
2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, ON
Vergleichen Sie PROF mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PROF
Profound Medical Corp
|
6.09 | 202.86M | 8.98M | -31.39M | -24.83M | -1.34 |
|
ABT
Abbott Laboratories
|
134.11 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
103.63 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
391.81 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
88.28 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.02 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Profound Medical Corp Stock (PROF) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-23 | Eingeleitet | Lake Street | Buy |
| 2024-07-16 | Hochstufung | Stifel | Hold → Buy |
| 2023-11-28 | Eingeleitet | Stifel | Hold |
| 2023-08-04 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-03-21 | Herabstufung | Jefferies | Buy → Hold |
| 2020-09-15 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Profound Medical Corp Aktie (PROF) Neueste Nachrichten
(PRN) Stock Trading Blueprint (PRN:CA) - news.stocktradersdaily.com
Profound Medical: Top 10 Undervalued Medical Devices & Instruments Industry Stocks (PRN) - The Globe and Mail
How To Trade (PRN) (PRN:CA) - news.stocktradersdaily.com
Global Uterine Fibroids Treatment Devices Market is - GlobeNewswire
(PRN) Advanced Equity Analysis (PRN:CA) - news.stocktradersdaily.com
Following a 26% decline over last year, recent gains may please Profound Medical Corp. (TSE:PRN) institutional owners - simplywall.st
Profound Medical (NASDAQ:PROF) Shares Up 17.4% – What’s Next? - Defense World
Regulatory Affairs in Life Sciences - Fasken
Profound Medical (PROF) Advances BPH Treatment with New Module | - GuruFocus
Profound Medical announces first commercial BPH treatment using TULSA-AI - TipRanks
Profound Medical (PROF) Advances BPH Treatment with New Module | PROF Stock News - GuruFocus
Profound Medical Brief: Announcing First Commercial BPH Patient Treatment Using TULSA-PRO with TULSA-AI Volume Reduction - MarketScreener
Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction - Yahoo Finance
(PRN) Trading Performance and Risk Management (PRN:CA) - news.stocktradersdaily.com
Learn to Evaluate (PRN) using the Charts (PRN:CA) - news.stocktradersdaily.com
Profound Medical (PROF) Partners with Leonard Wheeler to Boost T - GuruFocus
Profound Medical (PROF) Partners with Leonard Wheeler to Boost TULSA-PRO Awareness | PROF Stock News - GuruFocus
Profound Medical Partners with NFL Legend Leonard Wheeler to Promote TULSA-PRO - TipRanks
Profound Medical enters agreement with former NFL player Leonard Wheeler - TipRanks
Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassado - GuruFocus
Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassador For TULSA-PRO® | PROF Stock News - GuruFocus
Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassador For TULSA-PRO® - The Manila Times
(PRN) Equity Market Report (PRN:CA) - news.stocktradersdaily.com
(PRN) Trading Report (PRN:CA) - news.stocktradersdaily.com
Long Term Trading Analysis for (PRN) (PRN:CA) - news.stocktradersdaily.com
Where are the Opportunities in (PRN) (PRN:CA) - news.stocktradersdaily.com
1 Magnificent Healthcare Stock Down 80% to Buy and Hold Forever - MSN
(PRN) Stock Market Analysis (PRN:CA) - news.stocktradersdaily.com
Profound Medical CEO Arun Menawat buys $100,150 in shares By Investing.com - Investing.com Canada
Insider Buying: Arun Menawat Acquires Shares of Profound Medical Corp (PROF) - GuruFocus
Profound Medical CEO Arun Menawat buys $100,150 in shares - Investing.com Australia
Profound Medical targets 70%-75% growth in 2025 with new TULSA AI module launch - MSN
Arun Menawat Bought 2.1% More Shares In Profound Medical - Yahoo Finance
(PRN) Financial Trading Report (PRN:CA) - news.stocktradersdaily.com
Profound Medical announces shareholder vote results - Investing.com Australia
Objective long/short (PRN) Report (PRN:CA) - news.stocktradersdaily.com
Profound Medical Annual General and Special Meeting of Shareholders Voting Results - The Manila Times
Profound Medical announces shareholder vote results By Investing.com - Investing.com South Africa
Profound Medical Corp. Announces Successful Shareholder Meeting Outcomes - TipRanks
Profound Medical Annual General and Special Meeting of Shareholders Voting Results | PROF Stock News - GuruFocus
Why Coinbase Global Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket - Benzinga
(PRN) Pivots Trading Plans and Risk Controls (PRN:CA) - news.stocktradersdaily.com
Profound Medical First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
Profound Medical Corp. (NASDAQ:PROF) Q1 2025 Earnings Call Transcript - Insider Monkey
Profound Medical stock rating downgraded at Raymond James By Investing.com - Investing.com Nigeria
Profound Medical stock rating downgraded at Raymond James - Investing.com
Profound Medical (PROF) Downgraded by Raymond James Amid Economic Concerns | PROF Stock News - GuruFocus
Profound Medical Q1 2025 revenue jumps 82% - Medical Buyer
Profound Medical Corp (PROF) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic ... By GuruFocus - Investing.com Canada
Profound Medical Corp (PROF) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic ... - Yahoo Finance
Why Pinterest Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket - Benzinga
Finanzdaten der Profound Medical Corp-Aktie (PROF)
Umsatz
Nettogewinn
Free Cashflow
ENV
Profound Medical Corp-Aktie (PROF) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Menawat Arun Swarup | CEO |
May 15 '25 |
Buy |
4.33 |
10,003 |
43,263 |
575,062 |
0.54%
1.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):